ArticleScientific reports2023

Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.

Caroline Bodet-Milin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.